Huang Caiqi, Liu Xiaoman, Feng Yanhui, Xiao Zhesi, Lu Zhengjia, Wang Lu, Ming Jia
Department of Breast and Thyroid Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Front Immunol. 2025 May 9;16:1588828. doi: 10.3389/fimmu.2025.1588828. eCollection 2025.
Connexin 43 (Cx43) plays a pivotal role in tumor growth, metastasis, and disease progression. This study employs bibliometric analysis to identify key research trends and emerging hotspots in Cx43-related solid tumor research.
In December 2024, the Web of Science Core Collection (WoSCC) database was searched for publications on Cx43 in solid tumor research from 2000 to 2024. Bibliometric analysis and data visualization were primarily conducted using CiteSpace, VOSviewer, and Bibliometrix, with a focus on visualizing aspects such as countries, institutions, journals, authors, references, and keywords in the field.
A total of 1,666 publications were retrieved, with the annual number of articles and citations continuing to grow. The United States and China had the highest number of publications, while the University of Western Ontario in Canada was the leading institution, with the most publications by Christian C.G. Nau. Lampe, P.D. was the most cited author. The International Journal of Molecular Sciences was the most frequently published journal, and the Journal of Biological Chemistry was the most frequently co-cited journal. High-frequency keywords included phosphorylation, breast cancer, gastric cancer, prognostic markers, anti-tumor immune response, and drug resistance.
Contemporary research focuses on the role of Cx43 phosphorylation in tumorigenesis, progression, and metastasis, its potential as a prognostic biomarker, and its critical role as an immunotherapeutic target and in tumor drug resistance. These studies provide a comprehensive analysis for a deeper understanding of the role of Cx43 in solid tumors and help to promote further research in this area.
连接蛋白43(Cx43)在肿瘤生长、转移和疾病进展中起关键作用。本研究采用文献计量分析来确定Cx43相关实体瘤研究的关键研究趋势和新兴热点。
2024年12月,在Web of Science核心合集(WoSCC)数据库中检索2000年至2024年关于Cx43在实体瘤研究方面的出版物。文献计量分析和数据可视化主要使用CiteSpace、VOSviewer和Bibliometrix进行,重点是可视化该领域的国家、机构、期刊、作者、参考文献和关键词等方面。
共检索到1666篇出版物,文章数量和被引次数逐年持续增长。美国和中国的出版物数量最多,而加拿大的西安大略大学是领先机构,Christian C.G. Nau发表的文章最多。Lampe, P.D.是被引次数最多的作者。《国际分子科学杂志》是发表频率最高的期刊,《生物化学杂志》是被共同引用频率最高的期刊。高频关键词包括磷酸化、乳腺癌、胃癌、预后标志物、抗肿瘤免疫反应和耐药性。
当代研究聚焦于Cx43磷酸化在肿瘤发生、进展和转移中的作用,其作为预后生物标志物的潜力,以及其作为免疫治疗靶点和在肿瘤耐药性中的关键作用。这些研究为深入理解Cx43在实体瘤中的作用提供了全面分析,并有助于推动该领域的进一步研究。